0.1788  0.003 (1.48%)		04-17 16:00
Open: 0.1792 High: 0.1825 Volume: 3,729,595		Pre. Close: 0.1762 Low: 0.1732 Market Cap: 19(M)

Short term
Mid term
Targets	6-month :	0.28	1-year :	0.35
Resists	First :	0.24	Second :	0.3
Pivot price	0.17
Supports	First :	0.15	Second :	0.12
MAs	MA(5) :	0.16	MA(20) :	0.18
	MA(100) :	0.24	MA(250) :	0.44
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	40.6	D(3) :	27.6
RSI	RSI(14): 46.1
52-week	High :	0.93	Low :	0.15

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ VNRX ] has closed below upper band by 46.9%. Bollinger Bands are 31.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	0.18 - 0.18	0.18 - 0.18
Low:	0.17 - 0.17	0.17 - 0.17
Close:	0.18 - 0.18	0.18 - 0.18

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.

Fri, 17 Apr 2026
VolitionRx Sets One-for-Twenty Reverse Stock Split - TipRanks

Fri, 17 Apr 2026
VolitionRx (VNRX) to execute 1-for-20 reverse stock split on April 28, 2026 - Stock Titan

Fri, 17 Apr 2026
VolitionRx Limited Schedules Full Fiscal Year 2025 Earnings Conference Call and Business Update - Eastern Progress

Thu, 16 Apr 2026
VNRX Stock Price, Quote & Chart | VOLITIONRX LTD (NYSEARCA:VNRX) - ChartMill

Wed, 01 Apr 2026
VolitionRx (NYSE: VNRX) wins approval for major share issue and reverse split - Stock Titan

Tue, 31 Mar 2026
VolitionRx Limited secures €2M non-dilutive funding from Belgian agencies - MSN

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: AMEX
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.